RESEARCHER PROFILE
Beata M. Labuz-Roszak
B
University of Opole
Beata M. Labuz-Roszak works in Acute Ischemic Stroke Management, Multiple Sclerosis Research Studies, Antiplatelet Therapy and Cardiovascular Diseases, Epilepsy research and treatment, Peripheral Neuropathies and Disorders. Recorded institutional associations include University of Opole.
171Publications
814Citations
13H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
MR-Guided Focused Ultrasound: A New Generation Treatment of Parkinson's Disease, Essential Tremor and Neuropathic Pain
2014 · 71 citationsFatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis
2012 · 66 citationsGlobal Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events
2022 · 48 citationsAutoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes
2023 · 33 citationsSafety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19
2022 · 31 citations[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
2013 · 29 citationsNo association between MRI changes in the lumbar spine and intensity of pain, quality of life, depressive and anxiety symptoms in patients with low back pain
2018 · 28 citationsPrevalence of pain in patients with multiple sclerosis and its association with anxiety, depressive symptoms and quality of life
2019 · 28 citationsAntioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
2012 · 27 citationsOral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
2012 · 17 citationsCalcium–phosphate metabolism in patients with multiple sclerosis
2015 · 15 citationsDifficulties in the diagnosis of autonomic dysfunction in multiple sclerosis
2007 · 14 citationsThe Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke
2019 · 14 citationsEssential tremor – assessment of tremor accelerometric parameters' symmetry and the relationship between hand dominance and severity of tremor
2011 · 13 citationsResistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking
2014 · 13 citationsThe usefulness of accelerometric registration with assessment of tremor parameters and their symmetry in differential diagnosis of parkinsonian, essential and cerebellar tremor
2012 · 12 citationsThe Physical and Mental Well-Being of Medical Doctors in the Silesian Voivodeship
2022 · 12 citationsEffect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes
2023 · 12 citationsCharacteristics of hospitalizations due to acute stroke in the Silesian Province, Poland, between 2009 and 2015
2017 · 11 citationsASSOCIATION BETWEEN EATING HABITS AND PHYSICAL ACTIVITY IN PRIMARY SCHOOL STUDENTS
2020 · 11 citationsAssociation of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
2023 · 11 citationsRisk factor profile in patients with stroke at a young age
2018 · 10 citationsEarly and One-Year Outcomes of Acute Stroke in the Industrial Region of Poland During the Decade 2006–2015: The Silesian Stroke Registry
2018 · 10 citations[Definition and treatment of stroke over the centuries].
2018 · 10 citationsThe Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
2021 · 10 citations
